Molecular imaging: Novel tools in visualizing rheumatoid arthritis

Rheumatology

Volumn 44, Issue 11, 2005, Pages 1341-1349

  Wunder, Andreas ^b,c   Straub, R H ^b   Gay, S ^a   Funk, J ^b   Muller Ladner U ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Magnetic resonance tomography; Nuclear imaging; Optical imaging; Radiography; Ultrasound

Indexed keywords

BUTAPROST; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PENTETIC ACID;

ANGIOGENESIS; APOPTOSIS; BIOLUMINESCENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; DISEASE ACTIVITY; FLUORESCENCE; GENE EXPRESSION; IN VIVO STUDY; INTERMETHOD COMPARISON; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; ULTRASOUND;

ANIMALS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR PROBES; POSITRON-EMISSION TOMOGRAPHY;

EID: 27844563670     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh709     Document Type: Review

References (36)

1. Taylor PC. The value of sensitive imaging modalities in rheumatoid arthritis. Arthritis Res Ther 2003;5:210-3.
2. Peterfy CG. New developments in imaging in rheumatoid arthritis. Curr Opin Rheumatol 2003;15:288-95.
3. Hoving JL, Buchbinder R, Hall S et al. A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. J Rheumatol 2004;31: 663-75.
4. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219:316-33.
5. Massoud TF, Gambhir SS. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
6. Herschman HR. Molecular imaging: Looking at problems, seeing solutions. Science 2003;302:605-8.
7. Wunder A, Grimm J, Müller-Ladner U. Molecular imaging in rheumatoid arthritis. Z Rheumatol 2003;62:II33-6.
8. Biswal S. Molecular imaging of musculoskeletal diseases. Semin Musculoskelet Radiol 2003;7:317-50.
9. Weissleder R. Scaling down imaging: Molecular mapping of cancer in mice. Nat Rev Cancer 2002;2:11-8.
10. Cherry SR. In vivo molecular and genomic imaging: New challenges for imaging physics. Phys Med Biol 2004;49:R13-48.
11. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8.
12. Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging 2002;16:362-77.
13. Lindner JR. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 2004;11:215-21.
14. Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolio E, Maggioni F. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 2002;16:394-406.
15. Artemov D. Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem 2003;90:518-24.
16. Blankenberg FG, Strauss HW. Nuclear medicine applications in molecular imaging. J Magn Reson Imaging 2002;16:352-61.
17. Hnatowich DJ. Observations on the role of nuclear medicine in molecular imaging. J Cell Biochem Suppl 2002;39:18-24.
18. Louie AY, Huber MM, Ahrens ET et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000;18:321-5.
19. Bogdanov A Jr, Matuszewski L, Bremer C, Petrovsky A, Weissleder R. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 2002;1:16-23.
20. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 2002;20:816-20.
21. Barrera P, van der Laken CJ, Boerman OC et al. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology 2000;39:870-4.
22. Barrera P, Oyen WJ, Boerman OC, van Riel PL. Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:825-8.
23. Gaal J, Mezes A, Siro B et al. 99m Tc-HMPAO labelled leukocyte scintigraphy in patients with rheumatoid arthritis: A comparison with disease activity. Nucl Med Commun 2002;23:39-46.
24. Zinn KR, Chaudhuri TR, Smyth CA et al. Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptide. Arthritis Rheum 1999; 42:641-9.
25. Jamar F, Houssiau FA, Devogelaer JP et al. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002;41:53-61.
26. Roivainen A, Parkkola R, Yli-Kerttula T et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 2003;48:3077-84.
27. Polisson RP, Schoenberg OI, Fischman A et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:819-25.
28. Palmer WE, Rosenthal DI, Schoenberg OI et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 196:647-55.
29. Beckers C, Ribbens C, Andre B et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004; 45:956-64.
30. Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med 2002; 43:1359-65.
31. Hansch A, Frey O, Sauner D et al. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 2004;50: 961-7.
32. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 2002;168:1441-6.
33. Nakajima A, Seroogy CM, Sandora MR et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001;107:1293-301.
34. Tarner IH, Slavin AJ, McBride J et al. Treatment of autoimmune disease by adoptive cellular gene therapy. Ann N Y Acad Sci 2003; 998:512-9.
35. Wunder A, Schellenberger E, Mahmood U et al. Methotrexate induced accumulation of fluorescent annexin V in collagen induced arthritis. Mol Imaging 2005 (in press).
36. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: A novel approach for monitoring treatment response. Arthritis Rheum 2004;50:2459-65.